Please try another search
TBG Diagnostics Ltd, a molecular diagnostics company, develops, manufactures, and markets molecular diagnostics kits, instruments, and services in the United States, Taiwan, and China. Its reagents include COVID 19 testing, HLA SSP and HLA SBT typing, HPA genotyping, and Nucleic Acid Extraction kits; Reagents and Accessories; Holotype HLA NGS; and reagent analysis software. The company offers equipment, such as nucleic acid extraction, automated pipetting, and real time PCR Systems. In addition, it provides HLA-typing services, as well as engages in research and development. The company serves clinical labs, blood centers, and bone marrow registry labs. TBG Diagnostics Ltd was formerly known as Progen Pharmaceuticals Limited and changed its name to TBG Diagnostics Ltd in December 2015. The company was incorporated in 1989 is based in New Taipei City, Taiwan.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review